IP Library Patent Application 16456078
Patent Application
App. No. 16/456,078

COMPOSITIONS AND METHODS FOR AGONIZING THE CB2 RECEPTOR

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/456,078
Abstract

Disclosed herein are new compositions comprising a purified cannabinoid and a purified terpene. In one embodiment, the compositions comprise one or more purified cannabinoids. In one embodiment, the compositions comprise one or more purified cannabinoids in combination with one or more purified terpenes. In one embodiment, the compositions comprise unnaturally occurring ratios. In one embodiment, the compositions comprise unnaturally occurring concentrations. In one embodiment, the compositions comprise unexpected and/or synergistic effects.

Claims (15)

1 . A composition comprising:

purified CBC;

wherein the composition is substantially free from cellulose; and

wherein the purified CBC makes up greater than 50% of the total cannabinoids present in the composition.

2 . The composition of claim 1 , further comprising a compound chosen from a second purified cannabinoid, a purified terpene, and an analgesic.

3 . The composition of claim 2 , further comprising a purified terpene chosen from Linalool, Borneol, Elemene, Beta-Myrcene, Nerolidol, Phytol, Terpinolene, Bornyl Acetate, and Terpineol, alpha bisabolol.

4 . The composition of claim 2 , further comprising an analgesic.

5 . The composition of claim 4 , wherein the analgesic is chosen from Morphine, Thebaine, Buprenorphine, Fentanyl, Acetylfentanyl, Norfentanyl, 3-Methylfentanyl, Carfentanil, Alfentanil, Oxymorphone, Noroxymorphone, Hydromorphone, Tapentadol, Oxycodone, Hydrocodone, eroin, Diacetylmorphine, Codeine, Meperidine, Dextropropoxyphene, Papaverine, Levacetylmethado, Tramadol, Levorphanol, Methadone, Butorphanol, Pentazocine, and Nalbuphine.

6 . A method of agonizing the CB2 receptor comprising administering a composition comprising purified CBC to a subject in need thereof.

7 . A method of treating pain comprising administering a composition comprising purified CBC to a subject in need thereof.

8 . The method of claim 7 , further comprising administering an analgesic.

9 . The method of claim 8 , wherein the analgesic is chosen from chosen from Morphine, Thebaine, Buprenorphine, Fentanyl, Acetylfentanyl, Norfentanyl, 3-Methylfentanyl, Carfentanil, Alfentanil, Oxymorphone, Noroxymorphone, Hydromorphone, Tapentadol, Oxycodone, Hydrocodone, Heroin, Diacetylmorphine, Codeine, Meperidine, Dextropropoxyphene, Papaverine, Levacetylmethado, Tramadol, Levorphanol, Methadone, Butorphanol, Pentazocine, and Nalbuphine.

10 . The method of claim 9 , comprising reducing the amount of analgesic administered to the subject compared to the amount of analgesic required in the absence of CBC.

11 . A method of reducing inflammation comprising administering a composition comprising purified CBC to a subject in need thereof.

12 . A method of treating inflammatory disease comprising administering a composition comprising purified CBC to a subject in need thereof.

Assignments (4)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 22, 2021
From: CANOPY GROWTH CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055683/0826 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2019
From: REID, BRIAN GEOFFREY; COOPER, JONATHAN MICHAEL
To: EBBU, LLC
Reel/Frame 049628/0212 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2019
From: EBBU INC.
To: CANOPY GROWTH CORPORATION
Reel/Frame 049628/0229 →
CHANGE OF NAME Recorded Jun 28, 2019
From: EBBU, LLC
To: EBBU INC.
Reel/Frame 051489/0073 →